Turid Aas
- Oncology top 0.2%
- Molecular Biology top 1%
- Cancer Research top 0.1%
- Genetics top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Co-authors
- Per Eystein LønningStephanie GeislerHilde JohnsenAnne‐Lise Børresen‐DaleThérese SørlieCharles M. PerouDavid BotsteinPatrick O. Brown
- Topics
- Breast Cancer Treatment Studies (23 papers)Cancer-related Molecular Pathways (10 papers)Cancer Genomics and Diagnostics (8 papers)
In The Last Decade
Turid Aas
57 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 5.7k
- Molecular Biology 5.7k
- Cancer Research 5.3k
- Genetics 2.0k
- Pathology and Forensic Medicine 1.3k
Countries citing papers authored by Turid Aas
This map shows the geographic impact of Turid Aas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turid Aas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turid Aas more than expected).
Fields of papers citing papers by Turid Aas
This network shows the impact of papers produced by Turid Aas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turid Aas. The network helps show where Turid Aas may publish in the future.
Co-authorship network of co-authors of Turid Aas
This figure shows the co-authorship network connecting the top 25 collaborators of Turid Aas. A scholar is included among the top collaborators of Turid Aas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turid Aas. Turid Aas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 13 | |
| 5 | 27 | |
| 6 | 10 | |
| 7 | 32 | |
| 8 | 18 | |
| 9 | 32 | |
| 10 | 23 | |
| 11 | 8 | |
| 12 | 84 | |
| 13 | 51 | |
| 14 | 3 | |
| 15 | 13 | |
| 16 | 76 | |
| 17 | 97 | |
| 18 | Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. | 264 |
| 19 | 43 | |
| 20 | 33 |
About Turid Aas
Turid Aas is a scholar working on Cancer Research, Oncology and Family Practice, having authored 59 papers that have together received 11.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Cancer Research (5.3k citations), Oncology (5.7k citations) and Molecular Biology (5.7k citations). Turid Aas has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Per Eystein Lønning, Stephanie Geisler, Hilde Johnsen, Anne‐Lise Børresen‐Dale, Thérese Sørlie, Charles M. Perou, David Botstein, Patrick O. Brown, Matt van de Rijn and Stefanie S. Jeffrey. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.